Medicinal plants have been reported as high risk of kidney failure among consumers. Around 80% in sub-Saharan population consume medicinal plants. This present study aimed to evaluate the influence of everyday life consumption of anti-diabetic plants among diabetic patients. We performed an analytical study in 54 participants. In diabetic population, we included 27 consumers of anti-diabetic plants and 27 non-consumers. We made the kidney screening with the measurement of the serum creatinine, urine creatinine, serum urea and fasting blood glucose. We estimated the GFR with the creatinine clearance of 24h. We used questionnaire to collect socio-demographic and personal history data. We identified 4 anti-diabetic plants used by our participants which are Leptadenie hastata, Detarium microcarpum, Boswellia dalzielii and Moringa oleifera. The average value of fasting blood glucose was low in patient consumers of plants (166 ± 43 mg/dl) than in non-consumers (229±53 mg/dl). We noted that consumers of Moringa oleifera (148.14±42 mg/dl) and Leptadenia hastata (148.25±46 mg/dl) presented best values of fasting blood glucose. We noted high prevalence of stage 3 and 4 of CKD in consumers of plant extracts (15%) than non-consumers (7%). Patient consumers of Detarium microcarpum and Boswellia dalzielii presented average value of eGFR in stage 2 of CKD. Though, consumers of Moringa oleifera and Leptadenia hastata presented healthy status of kidney function (116 ml/min/1.73m2 and 115 ml/min/1.73m2) followed by non-consumers group (102 ml/min/1.73m2). These results showed that Moringa oleifera and Leptadenia hastate are better anti-diabetic plants for management of diabetes and they could have nephron-protection effect among diabetics.
Published in | Cardiology and Cardiovascular Research (Volume 1, Issue 2) |
DOI | 10.11648/j.ccr.20170102.15 |
Page(s) | 57-61 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2017. Published by Science Publishing Group |
Diabetes, Anti-diabetics, Plant, Ngaoundere, eGFR
[1] | WHO. World health report in 2013: research for universal health coverage. 2013. Luxembourg. |
[2] | FID. Atlas of diabetes. 6th Edition. 2013. FID. |
[3] | Gilles C. Diabetes in omnipratic. 3rd Edition. 2013. Edition Bas-Saint-Laurent Health and Social Services Agency, Rimouski (Quebec), Canada. |
[4] | Levey AS, Eckardt K-U, Tsukamoto Y et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005; 67:2089-2100. |
[5] | Krol DG. Chronic kidney disease staging and progression. In Henry Ford Medical Group. Chronic Kidney Disease (CKD): Clinical Practice Recommendations for Primary Care Physicians and Healthcare Providers. 6th Edition. Henry Ford Health System. A Collaborative approach. 2011; 2-10. |
[6] | Rimes-Stigare C, Frumento P, Bottai M, Mårtensson J, Martling CR and Bell M. Long-term mortality and risk factors for development of end-stage renal disease in critically ill patients with and without chronic kidney disease. Critical Care. 2015; 19(383):1-12. |
[7] | Grams ME, Liang L, Greene TH, Tin T, Sang Y, Kao L et al. Estimating Time to ESRD Using Kidney Failure Risk Equations: Results From the African American Study of Kidney Disease and Hypertension (AASK). Am J Kidney Dis. 2015; 65(3): 394-402. |
[8] | Henry Ford Medical Group. Chronic Kidney Disease (CKD): Clinical Practice Recommendations for Primary Care Physicians and Healthcare Providers. 6th Edition. Henry Ford Health System. A Collaborative approach. 2011. 76 Pp. |
[9] | Ngassam E., Nguewe J. L., Ongnessek S., Foutko A., Mendane F., Balla V., Limen S., Orr-Wamlek B., Sobngwi E., Mbanya J. C. Cost of managing type 2 diabetes at Yaoundé Central Hospital. Diabete Metab. 2012. 38:31-111. |
[10] | WHO. Traditional Medicine Strategy 2002-2005. WHO. 2002. Geneva. Amsterdam. |
[11] | WHO. Traditional Medicine Strategy in the World: 2014-2023. 2012. Hong Kong, 72. |
[12] | Saydah SH, Eberhardt MS: Use of complementary and alternative medicine among adults with chronic diseases: United States. 2002. J Altern Complement Med. 2006; 12(8):805–812. |
[13] | Hasan SS, Ahmed SI, Bukhari NI, Loon WCW. Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics. Complement Ther Clin Pract. 2009; 15(3):152–157. |
[14] | Moolasarn S, Sripa S, Kuesirikiet V, Sutawee K, Huasary J, Chaisila C, Chuechom N, Sankarn S. Usage of alternative medicine in cancer patients. Siriraj Med J. 2003; 55(6):307-323. |
[15] | Roglic G, Unwin N. Mortality attributable to diabetes: estimates for the year 2010. Diabetes Res Clin Pract. 2010; 87(1):15-23. |
[16] | Vliet VE. Medicinal plants for women’s and children’s health in urban and rural areas of Gabon: The harvest of wild and cultivated plants. Master thesis. Master of Environmental Biology, Utrecht University. 2012. Utrecht, Netherland. |
[17] | Sobngwi E, Boudou P, Mauvais-Jarvis F, Leblanc H, Velho G, Vexiau P, Porcher R, Hadjadj S, Pratley R, Tataranni PA, Calvo F, Gautier JF. Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet. 2003; 361(9372):1861-1865. |
[18] | Darragh ON, Britton A, Brunner EJ, Bell S. Twenty-Five-Year Alcohol Consumption Trajectories and Their Association with Arterial Aging: A Prospective Cohort Study. J Am Heart Assoc. 2017; 6: e005288-e005301. |
[19] | Sanda KA, Sandabe UK, Awal MS, Bulama U, Bashir MT, Sanda FA and Maigari IA. Hypoglycemic and antidiabetic profile of the Aqueous Root Extracts of Leptadenia in Albions Rats. 2013. Pakistan J Biomed Sci. 16(4):190-194. |
[20] | Ampofo O. The practice of phytotherapy in Ghana. 1979. African med plant. Sifowora, University of Ile-Ife press, Ile-Ife, Nigeria. |
[21] | Bello A, Aliero AA, Saidu Y, Muhammad S. Hypoglycaemic and Hypolipidaemic Effects of Leptadenia hastata (Pers.) Decne in Alloxan Induced Diabetic Rats.. Nigerian J of Basic Applied Sci. 2011; 19 (2):187-211. |
[22] | Zeba AN, Nutritional transition and double burden of malnutrition among adults in Ouagadougou, Burkina Faso (West Africa). 2012. Phd thesis, University of Montreal, Montreal, Canada. |
[23] | Biolabo. Calorimetric method: reagent for the quantitative determination of urea in human serum and plasma, or urine. 2011. Biolabo SA, France. |
[24] | Owiredu WKBA, Quaye L, Amidu N, Addai-Mensah O. Renal insufficiency in Ghanaian HIV infected patients: need for dose adjustment. Afri Health Sci. 2013; 3(1):101-111. |
[25] | Tourneux H., et Dairou Y. Fulani Dictionary of Agriculture and Nature; Followed by a French-fulfulde index of the Diamare, Cameroon. Edition Karthala, Paris, France. |
APA Style
Mbarawa Kofia Ibrahim, Ngah Esther, Ndoe Guiaro Marcellin, Gilles Mache, Tamanji Marcel Nanji, et al. (2017). Biological Investigation of the Benefits and Risk of Plants Consumed by Diabetics in Ngaoundere. Cardiology and Cardiovascular Research, 1(2), 57-61. https://doi.org/10.11648/j.ccr.20170102.15
ACS Style
Mbarawa Kofia Ibrahim; Ngah Esther; Ndoe Guiaro Marcellin; Gilles Mache; Tamanji Marcel Nanji, et al. Biological Investigation of the Benefits and Risk of Plants Consumed by Diabetics in Ngaoundere. Cardiol. Cardiovasc. Res. 2017, 1(2), 57-61. doi: 10.11648/j.ccr.20170102.15
@article{10.11648/j.ccr.20170102.15, author = {Mbarawa Kofia Ibrahim and Ngah Esther and Ndoe Guiaro Marcellin and Gilles Mache and Tamanji Marcel Nanji and Sitty Eguessa and Nwabo Kamdje Armel and Zofou Denis and Assob Nguedia}, title = {Biological Investigation of the Benefits and Risk of Plants Consumed by Diabetics in Ngaoundere}, journal = {Cardiology and Cardiovascular Research}, volume = {1}, number = {2}, pages = {57-61}, doi = {10.11648/j.ccr.20170102.15}, url = {https://doi.org/10.11648/j.ccr.20170102.15}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ccr.20170102.15}, abstract = {Medicinal plants have been reported as high risk of kidney failure among consumers. Around 80% in sub-Saharan population consume medicinal plants. This present study aimed to evaluate the influence of everyday life consumption of anti-diabetic plants among diabetic patients. We performed an analytical study in 54 participants. In diabetic population, we included 27 consumers of anti-diabetic plants and 27 non-consumers. We made the kidney screening with the measurement of the serum creatinine, urine creatinine, serum urea and fasting blood glucose. We estimated the GFR with the creatinine clearance of 24h. We used questionnaire to collect socio-demographic and personal history data. We identified 4 anti-diabetic plants used by our participants which are Leptadenie hastata, Detarium microcarpum, Boswellia dalzielii and Moringa oleifera. The average value of fasting blood glucose was low in patient consumers of plants (166 ± 43 mg/dl) than in non-consumers (229±53 mg/dl). We noted that consumers of Moringa oleifera (148.14±42 mg/dl) and Leptadenia hastata (148.25±46 mg/dl) presented best values of fasting blood glucose. We noted high prevalence of stage 3 and 4 of CKD in consumers of plant extracts (15%) than non-consumers (7%). Patient consumers of Detarium microcarpum and Boswellia dalzielii presented average value of eGFR in stage 2 of CKD. Though, consumers of Moringa oleifera and Leptadenia hastata presented healthy status of kidney function (116 ml/min/1.73m2 and 115 ml/min/1.73m2) followed by non-consumers group (102 ml/min/1.73m2). These results showed that Moringa oleifera and Leptadenia hastate are better anti-diabetic plants for management of diabetes and they could have nephron-protection effect among diabetics.}, year = {2017} }
TY - JOUR T1 - Biological Investigation of the Benefits and Risk of Plants Consumed by Diabetics in Ngaoundere AU - Mbarawa Kofia Ibrahim AU - Ngah Esther AU - Ndoe Guiaro Marcellin AU - Gilles Mache AU - Tamanji Marcel Nanji AU - Sitty Eguessa AU - Nwabo Kamdje Armel AU - Zofou Denis AU - Assob Nguedia Y1 - 2017/05/18 PY - 2017 N1 - https://doi.org/10.11648/j.ccr.20170102.15 DO - 10.11648/j.ccr.20170102.15 T2 - Cardiology and Cardiovascular Research JF - Cardiology and Cardiovascular Research JO - Cardiology and Cardiovascular Research SP - 57 EP - 61 PB - Science Publishing Group SN - 2578-8914 UR - https://doi.org/10.11648/j.ccr.20170102.15 AB - Medicinal plants have been reported as high risk of kidney failure among consumers. Around 80% in sub-Saharan population consume medicinal plants. This present study aimed to evaluate the influence of everyday life consumption of anti-diabetic plants among diabetic patients. We performed an analytical study in 54 participants. In diabetic population, we included 27 consumers of anti-diabetic plants and 27 non-consumers. We made the kidney screening with the measurement of the serum creatinine, urine creatinine, serum urea and fasting blood glucose. We estimated the GFR with the creatinine clearance of 24h. We used questionnaire to collect socio-demographic and personal history data. We identified 4 anti-diabetic plants used by our participants which are Leptadenie hastata, Detarium microcarpum, Boswellia dalzielii and Moringa oleifera. The average value of fasting blood glucose was low in patient consumers of plants (166 ± 43 mg/dl) than in non-consumers (229±53 mg/dl). We noted that consumers of Moringa oleifera (148.14±42 mg/dl) and Leptadenia hastata (148.25±46 mg/dl) presented best values of fasting blood glucose. We noted high prevalence of stage 3 and 4 of CKD in consumers of plant extracts (15%) than non-consumers (7%). Patient consumers of Detarium microcarpum and Boswellia dalzielii presented average value of eGFR in stage 2 of CKD. Though, consumers of Moringa oleifera and Leptadenia hastata presented healthy status of kidney function (116 ml/min/1.73m2 and 115 ml/min/1.73m2) followed by non-consumers group (102 ml/min/1.73m2). These results showed that Moringa oleifera and Leptadenia hastate are better anti-diabetic plants for management of diabetes and they could have nephron-protection effect among diabetics. VL - 1 IS - 2 ER -